February 6, 2019

The Early Diagnosis of Alzheimer’s Disease: Delineating the Cause of Memory Impairment

6th Congress of the European Academy of Neurology 2020

Comprehensive Cognitive Assessment to Facilitate an Early Diagnosis

Wiesje van der Flier, PhD, discusses the essential role of cognitive assessments in the diagnosis of Alzheimer’s disease. She describes the domains of cognition and cognitive trajectories in Alzheimer’s disease and discusses the use of comprehensive cognitive assessments, including building a full neuropsychological battery to assess all cognitive domains, alongside assessment of function and behavior. She also discusses the role of telemedicine in cognitive screening. She then discusses the cognitive assessment results from the patient case.

Key Learning Objectives for Biogen’s EAN 2020 Symposium:

  • Understand the value of an early diagnosis of Alzheimer’s disease
  • Gain insights on how comprehensive cognitive assessment tools and fluid and imaging biomarkers can be used to achieve an accurate and timely diagnosis of mild cognitive impairment due to Alzheimer’s disease
  • Assess the current healthcare system readiness for a paradigm shift to early diagnosis

Disclosure: All panelists received honoraria from Biogen for participation in this symposium.

Disclaimer: All of the information discussed today is for informational purposes only; does not constitute medical advice; and is not intended to be a substitute for independent professional medical judgment, advice, diagnosis, or treatment.